About Zinc finger protein 678
Zinc finger protein 678 (ZNF678) is a protein
from Homo sapiens identified by UniProt accession
Q5SXM1, 525 residues long.
MolForge cross-references it against 0 known binders and
54 disease associations.
Target properties
| Protein name | Zinc finger protein 678 |
| UniProt accession | Q5SXM1 |
| Gene | ZNF678 |
| Organism | Homo sapiens |
| Length | 525 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (54)
Diseases linked to this target (Open Targets).
- body fat distribution · score 0.37
- body height · score 0.37
- BMI-adjusted waist circumference · score 0.33
- BMI-adjusted hip circumference · score 0.31
- grip strength measurement · score 0.29
- osteoarthritis, hand · score 0.29
- forced expiratory volume · score 0.26
- BMI-adjusted waist-hip ratio · score 0.25
- waist-hip ratio · score 0.25
- vital capacity · score 0.22
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q5SXM1-F1 | alphafold | PREDICTED | 75.75 | — |
Amino-acid sequence (525 residues)
MGTISLCIGV CAFEGANTST SFYKLVYTAI LSYSIQDLLP EQDMKDLCQK VTLTRHRSWG LDNLHLVKDW RTVNEGKGQK EYCNRLTQCS STKSKIFQCI ECGRNFSWRS ILTEHKRIHT GEKPYKCEEC GKVFNRCSNL TKHKRIHTGE KPYKCDECGK VFNWWSQLTN HKKIHTGEKP YKCDECDKVF NWWSQLTSHK KIHSGEKPYP CEECGKAFTQ FSNLTQHKRI HTGEKPYKCK ECCKAFNKFS NLTQHKRIHT GEKPYKCEEC GNVFNECSHL TRHRRIHTGE KPYKCEECGK AFTQFASLTR HKRIHTGEKP YQCEECGKTF NRCSHLSSHK RIHTGEKPYK CEECGRTFTQ FSNLTQHKRI HTGEKPYKCK ECGKAFNKFS SLTQHRRIHT GVKPYKCEEC GKVFKQCSHL TSHKRIHTGE KPYKCKECGK AFYQSSILSK HKRIHTEEKP YKCEECGKAF NQFSSLTRHK RIHTGEKRYK CKECGKGFYQ SSIHSKYKRI YTGEEPDKCK KCGSL
Explore Zinc finger protein 678 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets